These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7068981)
21. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model. Rodríguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852 [TBL] [Abstract][Full Text] [Related]
22. Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancer. Shealy YF; Frye JL; Riordan JM; Hill DL; McPhillips M; Wille JJ; Sani BP; Kalin JR; Eto I; Grubbs CJ Anticancer Drug Des; 1997 Jan; 12(1):15-33. PubMed ID: 9051111 [TBL] [Abstract][Full Text] [Related]
23. 13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat. Sporn MB; Squire RA; Brown CC; Smith JM; Wenk ML; Springer S Science; 1977 Feb; 195(4277):487-9. PubMed ID: 835006 [TBL] [Abstract][Full Text] [Related]
24. Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Udeani GO; Gerhauser C; Thomas CF; Moon RC; Kosmeder JW; Kinghorn AD; Moriarty RM; Pezzuto JM Cancer Res; 1997 Aug; 57(16):3424-8. PubMed ID: 9270008 [TBL] [Abstract][Full Text] [Related]
26. Correlation between retinoid inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis and levels of retinoic acid binding proteins. Mehta RG; McCormick DL; Cerny WL; Moon RC Carcinogenesis; 1982; 3(1):89-91. PubMed ID: 6279325 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of carcinogenesis by retinoids. Nettesheim P Can Med Assoc J; 1980 Apr; 122(7):757-65. PubMed ID: 6988069 [TBL] [Abstract][Full Text] [Related]
28. Anhydroretinol, a retinoid active in preventing mammary cancer induced in rats by N-methyl-N-nitrosourea. Shealy YF; Hill DL; Sani BP; Eto I; Juliana MM; Crubbs CJ Oncol Rep; 1998; 5(4):857-60. PubMed ID: 9625832 [TBL] [Abstract][Full Text] [Related]
29. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566 [TBL] [Abstract][Full Text] [Related]
30. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy. McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of some new retinoids for cancer chemoprevention. Shealy YF Prev Med; 1989 Sep; 18(5):624-45. PubMed ID: 2694159 [TBL] [Abstract][Full Text] [Related]
32. Retinoids as chemopreventive and anticancer agents intact animals (review). Hill DL; Grubbs CJ Anticancer Res; 1982; 2(1-2):111-24. PubMed ID: 6810745 [TBL] [Abstract][Full Text] [Related]
33. Vitamin A, retinoids and breast cancer. Moon RC Adv Exp Med Biol; 1994; 364():101-7. PubMed ID: 7725952 [TBL] [Abstract][Full Text] [Related]
34. Experiments on the influence of an aromatic retinoid on the chemical carcinogenesis in rats by butyl-butanol-nitrosamine and 1,2-dimethylhydrazine. Schmähl D; Habs M Arzneimittelforschung; 1978; 28(1):49-51. PubMed ID: 580198 [TBL] [Abstract][Full Text] [Related]
35. [Anti-carcinogenic and anti-blastic effect of vitamin A in various modes of its administration to random-bred rats during carcinogenesis of the mammary gland, induced by 7,12-dimethylbenz(a)anthracene]. Piatchanina TV; Kartavova NS; Gutnik NS; Sidorik EP Eksp Onkol; 1989; 11(5):20-3. PubMed ID: 2507271 [TBL] [Abstract][Full Text] [Related]
36. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors. Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393 [TBL] [Abstract][Full Text] [Related]
37. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency. Swanson SM; Christov K Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682 [TBL] [Abstract][Full Text] [Related]
38. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro. Welsch CW; DeHoog JV; Scieszka KM; Aylsworth CF Cancer Res; 1984 Jan; 44(1):166-71. PubMed ID: 6360344 [TBL] [Abstract][Full Text] [Related]
39. Retinoid prevents transformation of cultured mammary glands by procarcinogens but not by many activated carcinogens. Dickens MS; Sorof S Nature; 1980 Jun; 285(5766):581-4. PubMed ID: 6772960 [No Abstract] [Full Text] [Related]
40. Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth. Abou-Issa HM; Alshafie GA; Curley RW; Wong MF; Clagett-Dame M; Repa JJ; Sikri V Anticancer Res; 1999; 19(2A):999-1004. PubMed ID: 10368645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]